(Total Views: 392)
Posted On: 08/24/2018 2:57:32 PM
Post# of 72446
Well...assuming we
Get a drug into phase 3. (1yr)
Get a drug through phase 3. (2yr)
Get approval of NDA.(1-2yr)
Ramp sales to "2 billion/yr as a low estimate" (3 yr)
Talking about 2025 to get to that kind of revenue. $2 billion in 2018 eliminates all risk, puts everyone deep in the green, and does it fast. Huge win for so shareholders.
Get a drug into phase 3. (1yr)
Get a drug through phase 3. (2yr)
Get approval of NDA.(1-2yr)
Ramp sales to "2 billion/yr as a low estimate" (3 yr)
Talking about 2025 to get to that kind of revenue. $2 billion in 2018 eliminates all risk, puts everyone deep in the green, and does it fast. Huge win for so shareholders.
(0)
(4)
